-
Mashup Score: 2Managing Diverse Hematologic Malignancies at #ASH24 - 10 day(s) ago
Join us at #ASH24 for “Managing Diverse Hematologic Malignancies,” where leading experts will discuss the latest treatment strategies and research. Gain insights into innovative approaches for various hematologic cancers and stay updated on key advancements in the field.
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 0Home - 10 day(s) ago
Tuesday, June 4 8:00 – 9:00 PM ET 5:00 – 6:00 PM PT PRESENTERS Jessica Steen, OD, FAAO NOVA Southeastern Fort Lauderdale, Florida Karl G. Stonecipher, MD University of North Carolina Greensboro, NC MIEBO ® (perfluorohexyloctane ophthalmic solution) is indicated fo r the treatment of the signs and symptoms of dry eye disease. MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO Instruct patients
Source: na.eventscloud.comCategories: General Medicine News, OphthalmologyTweet-
#PaidPartnership Join Drs. Stonecipher and Steen for an Educational Webinar on Dry Eye Disease. Registration: https://t.co/CJdzHUErHL #dryeye #eyecare #ophthalmology #optometry https://t.co/3FINnzMfLs
-
-
Mashup Score: 1Home - 10 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, Oncologists1Tweet-
🔬 Discover the latest on complement-based therapies for PNH! Enhance your skills in identifying patients and creating tailored care plans. 🗣️ Boost your confidence in using effective communication for shared decision-making. Click here: https://t.co/VwFESDOQgO #ASH24 https://t.co/iOEaZaNWbf
-
-
Mashup Score: 0
During this AHA 2024 event, Medscape’s expert faculty will provide a comprehensive update of ATTR-CM, including early symptom recognition, the prognostic value of biomarkers, and the latest data on current and emerging treatment options.
Source: na.eventscloud.comCategories: General Medicine News, CardiologistsTweet-
🔬 Explore how ATTR-CM mutations impact disease burden and the latest safety and efficacy data for new treatments. 📈 Discover the role of genetics and serum transthyretin in prognosis. Register now: https://t.co/DWYWQN98DA #ATTRCM #Cardiology #AHA24 https://t.co/16gnMRSGpE
-
-
Mashup Score: 0Managing Primary Biliary Cholangitis - 11 day(s) ago
Join Medscape on November 16, 2024 for a symposium on primary biliary cholangitis (PBC) designed to encourage the exchange of ideas between leaders in the field and attendees.
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet-
📊 Explore phase 3 trial data on PBC treatments! Enhance your skills in evaluating progressive PBC risk and gain confidence in integrating treatment goals that address both biochemical and patient-reported outcomes. Click for details: https://t.co/lUhekgoZjO https://t.co/Uc31VdjpYz
-
-
Mashup Score: 0Home - 11 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet-
🔍 Discover the natural history and evolving treatments for AL amyloidosis. 📈 Boost your competence in patient classification and care planning. 💡 Stay updated with crucial evidence to enhance multidisciplinary care. Click here now: https://t.co/p67b47FQnr #ASH24 https://t.co/FjB3JM2c8H
-
-
Mashup Score: 0
During this AHA 2024 event, Medscape’s expert faculty will provide a comprehensive update of ATTR-CM, including early symptom recognition, the prognostic value of biomarkers, and the latest data on current and emerging treatment options.
Source: na.eventscloud.comCategories: General Medicine News, CardiologistsTweet-
🔬 Explore how ATTR-CM mutations impact disease burden and the latest safety and efficacy data for new treatments. 📈 Discover the role of genetics and serum transthyretin in prognosis. Register now: https://t.co/DWYWQN98DA #ATTRCM #Cardiology #AHA24 https://t.co/16gnMRSGpE
-
-
Mashup Score: 0Home - 12 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet-
🔍 Discover the natural history and evolving treatments for AL amyloidosis. 📈 Boost your competence in patient classification and care planning. 💡 Stay updated with crucial evidence to enhance multidisciplinary care. Click here now: https://t.co/p67b47FQnr #ASH24 https://t.co/FjB3JM2c8H
-
-
Mashup Score: 0Home - 12 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, DermatologyTweet-
🔬 Explore the latest clinical trial data on emerging therapies for DLBCL at first relapse. 📚 Learn key 🔑 factors affecting CAR T-cell therapy eligibility and enhance your competence in selecting personalized treatments. 📊 Click here now: https://t.co/TytW5mYNdQ #ASH24 https://t.co/f3bbQVonlB
-
-
Mashup Score: 1Home - 13 day(s) ago
Activity Overview
Source: na.eventscloud.comCategories: General Medicine News, Oncologists1Tweet-
🔬 Discover the latest on complement-based therapies for PNH! Enhance your skills in identifying patients and creating tailored care plans. 🗣️ Boost your confidence in using effective communication for shared decision-making. Click here: https://t.co/VwFESDOQgO #ASH24 https://t.co/iOEaZaNWbf
-
📊 Stay updated on the standards of care for hematologic malignancies and enhance your skills in community-based management. 💉 Gain confidence in tailoring patient-centric treatment plans for optimal outcomes. https://t.co/GyrITa2TkL #Hematology #PatientCare #Oncology #ASH24 https://t.co/e8jMCIIuoC